therapeutic 557 words KG: GPR109A (HCAR2) Agonists for Neurodegeneration 2026-03-31
kind:therapeuticsection:therapeuticsstate:publishedtopic:gpr109amechanism:gpcrdisease:alzheimers-diseasedisease:parkinsons-disease
Contents

GPR109A (HCAR2) Agonists for Neurodegeneration

💊 Therapeutic Info
NameGPR109A (HCAR2) Agonists for Neurodegeneration
SummaryComprehensive coverage of GPR109A (Hydroxycarboxylic Acid Receptor 2) agonists for treating Alzheimer's, Parkinson's, and other neurodegenerative diseases through gut-brain axis modulation.

Knowledge Graph